David Hardisson
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 1%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Wnt/β-catenin signaling in development and cancer 8
- Oncology 40
- Cancer Cells and Metastasis 11
- Co-authors
- David Sarrió (14 shared papers)Gema Moreno‐Bueno (18 shared papers)Socorro Marıá Rodríguez-Pinilla (7 shared papers)José Palacios (24 shared papers)Marta Mendiola (45 shared papers)Amparo Cano (4 shared papers)José Palacios (1 shared paper)Francisco Calero Calero (6 shared papers)
- Journals
- Modern Pathology (6 papers)PLoS ONE (4 papers)Journal of Clinical Oncology (4 papers)Histopathology (4 papers)The American Journal of Surgical Pathology (4 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
David Hardisson
149 papers receiving 7.0k citations
David Hardisson's Hit Papers
Peers
Comparison fields: 5 of 128
- Cancer Research 1.6k
- Oncology 2.2k
- Obstetrics and Gynecology 475
- Reproductive Medicine 377
- Molecular Biology 3.2k
Countries citing papers authored by David Hardisson
This map shows the geographic impact of David Hardisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hardisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hardisson more than expected).
Fields of papers citing papers by David Hardisson
This network shows the impact of papers produced by David Hardisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hardisson. The network helps show where David Hardisson may publish in the future.
Co-authors
The 25 scholars most cited alongside David Hardisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 158 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype Hit paper breakdown → | 2008 | 845 |
| 2 | Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation Hit paper breakdown → | 2012 | 796 |
| 3 | 2006 | 277 | |
| 4 | 2006 | 217 | |
| 5 | 2007 | 199 | |
| 6 | 2002 | 197 | |
| 7 | 2003 | 170 | |
| 8 | 2008 | 168 | |
| 9 | 2010 | 168 | |
| 10 | 2003 | 153 | |
| 11 | 2004 | 152 | |
| 12 | 2005 | 138 | |
| 13 | 2011 | 136 | |
| 14 | Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. | 2003 | 117 |
| 15 | 2008 | 114 | |
| 16 | 2006 | 112 | |
| 17 | 2003 | 111 | |
| 18 | 2014 | 109 | |
| 19 | 2003 | 98 | |
| 20 | 2006 | 97 |
About David Hardisson
David Hardisson is a scholar working on Molecular Biology, Oncology, Cancer Research, Reproductive Medicine and Pathology and Forensic Medicine, having authored 158 papers that have together received 7.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (21 papers), Endometrial and Cervical Cancer Treatments (16 papers), Breast Cancer Treatment Studies (14 papers), Cancer Genomics and Diagnostics (12 papers), Cancer Cells and Metastasis (11 papers), Uterine Myomas and Treatments (9 papers), Wnt/β-catenin signaling in development and cancer (8 papers) and Cancer and Skin Lesions (8 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.2k citations), Obstetrics and Gynecology (475 citations), Reproductive Medicine (377 citations) and Molecular Biology (3.2k citations). David Hardisson has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include David Sarrió, Gema Moreno‐Bueno, Socorro Marıá Rodríguez-Pinilla, José Palacios, Marta Mendiola, Amparo Cano, José Palacios, Francisco Calero Calero, C. Lomas and Miriam Zimmermann. Their work appears in journals such as Modern Pathology, PLoS ONE, Journal of Clinical Oncology, Histopathology and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.